211
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Patient Perceptions of Switching to a Generic Dry Powder Inhaler – Increased Understanding Through Journey Mapping

ORCID Icon, , , , , , & ORCID Icon show all
Pages 1751-1768 | Received 16 Feb 2022, Accepted 23 Jun 2022, Published online: 06 Aug 2022

References

  • Brennan TA, Lee TH. Allergic to generics. Ann Intern Med. 2004;141(2):126–130. doi:10.7326/0003-4819-141-2-200407200-00011
  • Shrank WH, Cox ER, Fischer MA, Mehta J, Choudhry NK. Patients’ perceptions of generic medications. Health Aff. 2009;28(2):546–556. doi:10.1377/hlthaff.28.2.546
  • Maly J, Dosedel M, Kubena A, Vlcek J. Analysis of pharmacists’ opinions, attitudes and experiences with generic drugs and generic substitution in the Czech Republic. Acta Pol Pharm. 2013;70(5):923–931.
  • Roman B. Patients’ attitudes towards generic substitution of oral atypical antipsychotics: a questionnaire-based survey in a hypothetical pharmacy setting. CNS Drugs. 2009;23(8):693–701. doi:10.2165/00023210-200923080-00006
  • Dunne SS, Dunne CP. What do people really think of generic medicines? A systematic review and critical appraisal of literature on stakeholder perceptions of generic drugs. BMC Med. 2015;13(1):173. doi:10.1186/s12916-015-0415-3
  • Ganther JM, Kreling DH. Consumer perceptions of risk and required cost savings for generic prescription drugs. J Am Pharm Assoc. 2000;40(3):378–383. doi:10.1016/S1086-5802(16)31086-5
  • Losifescu A, Halm EA, McGinn T, Siu AL, Federman AD. Beliefs about generic drugs among elderly adults in hospital-based primary care practices. Patient Educ Couns. 2008;73(2):377–383. doi:10.1016/j.pec.2008.07.012
  • Keenum AJ, Devoe JE, Chisolm DJ, Wallace LS. Generic medications for you, but brand-name medications for me. Res Social Adm Pharm. 2012;8(6):574–578. doi:10.1016/j.sapharm.2011.12.004
  • Sewell K, Andreae S, Luke E, Safford MM. Perceptions of and barriers to use of generic medications in a rural African American population, Alabama, 2011. Prev Chronic Dis. 2012;9:E142. doi:10.5888/pcd9.120010
  • Piette J. Cost-related medication underuse. A window into patients’ medication related concerns. Diabetes Spectr. 2009;22(2):77–80. doi:10.2337/diaspect.22.2.77
  • Figueiras MJ, Alves NC, Marcelino D, Cortes MA, Weinman J, Horne R. Assessing lay beliefs about generic medicines: development of the generic medicines scale. Psychol Health Med. 2009;14(3):311–321. doi:10.1080/13548500802613043
  • Omojasola A, Hernandez M, Sansgiry S, Jones L. Perceptions of generic prescription drugs and utilization of generic drug discount programs. Ethn Dis. 2012;22(4):479–485.
  • Gaither CA, Kirking DM, Ascione FJ, Welage LS. Consumers’ views on generic medications. J Am Pharm Assoc. 2001;41:729–736. doi:10.1016/S1086-5802(16)31308-0
  • Kesselheim AS, Gagne JJ, Franklin JM, et al. Variations in patients’ perceptions and use of generic drugs: results of a national survey. J Gen Intern Med. 2016;31(6):609–614. doi:10.1007/s11606-016-3612-7
  • Wheaton AG, Cunningham TJ, Ford ES, Croft JB. Employment and activity limitations among adults with chronic obstructive pulmonary disease—United States, 2013. MMWR Morb Mortal Wkly Rep. 2015;64(11):289.
  • Centers for Disease Control and Prevention. Most recent national asthma-data 2018; 2021. Available from: https://www.cdc.gov/asthma/most_recent_national_asthma_data.htm. Accessed September 29, 2021.
  • Booker R. Do patients think that dry powder inhalers can be used interchangeably? Int J Clin Pract. 2005;59(s149):30–32. doi:10.1111/j.1368-504X.2005.00725.x
  • Doyle S, Lloyd A, Williams A, et al. What happens to patients who have their asthma device switched without their consent? Prim Care Respir J. 2010;19(2):131–139. doi:10.4104/pcrj.2010.00009
  • Ding B, Small M, Scheffel G, Holmgren U. Maintenance inhaler preference, attribute importance, and satisfaction in prescribing physicians and patients with asthma, COPD, or asthma–COPD overlap syndrome consulting for routine care. Int J Chron Obstruct Pulmon Dis. 2018;13:927. doi:10.2147/COPD.S154525
  • Kaplan A, van Boven JF. Switching inhalers: a practical approach to keep on UR RADAR. Pulm Ther. 2020;6(2):381–392. doi:10.1007/s41030-020-00133-6
  • Lavorini F, Braido F, Baiardini I, Blasi F, Canonica GW. Asthma and COPD: interchangeable use of inhalers. A document of Italian Society of Allergy, Asthma and Clinical Immmunology (SIAAIC) & Italian Society of Respiratory Medicine (SIMER). Pulm Pharmacol Ther. 2015;34:25–30. doi:10.1016/j.pupt.2015.07.005
  • Guest G, Namey E, McKenna K. How many focus groups are enough? Building an evidence base for nonprobability sample sizes. Field Methods. 2017;29(1):3–22. doi:10.1177/1525822X16639015
  • Parvanta C, Nelson DE, Harner RN. Public Health Communication: Critical Tools and Strategies. Burlington, MA: Jones & Bartlett Learning; 2017.
  • Følstad A, Kvale K. Customer journeys: a systematic literature review. J Serv Theory Pract. 2018;28(2):196–227. doi:10.1108/JSTP-11-2014-0261
  • Rosenbaum MS, Otalora ML, Ramírez GC. How to create a realistic customer journey map. Bus Horiz. 2017;60(1):143–150. doi:10.1016/j.bushor.2016.09.010
  • Bearnot B, Mitton JA. “You’re always jumping through hoops”: journey mapping the care experiences of individuals with opioid use disorder-associated endocarditis. J Addict Med. 2020;14(6):494–501. doi:10.1097/ADM.0000000000000648
  • Ridder EF, Dekkers T, Porsius JT, Kraan G, Melles M. The perioperative patient experience of hand and wrist surgical patients: an exploratory study using patient journey mapping. Patient Exp J. 2018;5(3):97–107. doi:10.35680/2372-0247.1273
  • Chun Tie Y, Birks M, Francis K. Grounded theory research: a design framework for novice researchers. SAGE Open Med. 2019;7:2050312118822927. doi:10.1177/2050312118822927
  • Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101. doi:10.1191/1478088706qp063oa
  • Morgan DL. Focus Groups as Qualitative Research. 2nd ed. Thousand Oaks, CA: Sage; 1997.
  • Kidd PS, Parshall MB. Getting the focus and the group: enhancing analytical rigor in focus group research. Qual Health Res. 2000;10(3):293–308. doi:10.1177/104973200129118453
  • Jones NA, Ross T, Lynam PP, Leitch A. Mental models: an interdisciplinary synthesis of theory and methods. Ecol Soc. 2011;16:art46. doi:10.5751/ES-03802-160146
  • Johnson-Laird P. Mental Models. Cambridge, MA: Harvard University Press; 1983.
  • Colgan S, Faasse K, Martin LR, Stephens MH, Grey A, Petrie KJ. Perceptions of generic medication in the general population, doctors and pharmacists: a systematic review. BMJ Open. 2015;5(12):e008915. doi:10.1136/bmjopen-2015-008915
  • GUIDANCE D. Comparative analyses and related comparative use human factors studies for a drug-device combination product submitted in an ANDA. Center for Drug Evaluation and Research (CDER); 2017.
  • Donohue JF, Burgoyne DS, Ward JK, Allan R, Koltun A, Cooper A. Wixela inhub: a generic equivalent treatment option for patients with asthma or COPD. Pulm Ther. 2021;7(1):47–57. doi:10.1007/s41030-020-00142-5
  • Wang Z, Ahluwalia SK, Newman B, Dhapare S, Zhao L, Luke MC. Medication cost-savings and utilization of generic Inhaled Corticosteroid (ICS) and Long-Acting Beta-Agonist (LABA) drug products in the USA. Ther Innov Regul Sci. 2022;56(2):346–357. doi:10.1007/s43441-021-00372-y
  • Conrad R, Lutter R. Generic competition and drug prices: new evidence linking greater generic competition and lower generic drug prices; 2019.
  • Lavorini F, Magnan A, Dubus JC, et al. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med. 2008;102(4):593–604. doi:10.1016/j.rmed.2007.11.003
  • Chrystyn H, van der Palen J, Sharma R, et al. Device errors in asthma and COPD: systematic literature review and meta-analysis. NPJ Prim Care Respir Med. 2017;27(1):1–10. doi:10.1038/s41533-017-0016-z
  • Schulte M, Osseiran K, Betz R, et al. Handling of and preferences for available dry powder inhaler systems by patients with asthma and COPD. J Aerosol Med Pulm Drug Deliv. 2008;21(4):321–328. doi:10.1089/jamp.2007.0634